Segment Reporting

3 Months Ended

Oct. 31, 2011

Segment Reporting

Segment Reporting Disclosure [Text Block]

NOTE 9 - SEGMENT INFORMATION

The following information is presented in accordance with ASC Topic 280, “Segment Reporting”,  for the six months ended October 31, 2011 and 2010, we operated in two reportable business segments - (1) snatural sweetener (stevioside) and (2) traditional Chinese medicines, organic herbal medicine, neutraceutical products, and veterinary medicines prepared from organic herbal ingredients. Our reportable segments are strategic business units that offer different products and are managed separately based on the fundamental differences in their operations.

Condensed financial information with respect to these reportable business segments for the three months ended October 31, 2011 and 2010 is as follows:

	Chinese  Medicines		Stevioside		Corporate and Other		Consolidated
(Unaudited)	2011	2010	2011	2010	2011	2010	2011		2010
Net revenues	$852,110	$521,097	$2,715,060	$1,779,964	-	-	$3,567,170		$2,301,061
Interest income	4,133	12	8,539	8,422	3,592	-	16,264		8,434
Depreciation and amortization	19,375	18,357	355,873	366,832	-	-	375,248		385,189
Loss from continuing operations before taxes and noncontrolling interest	(170,331)	(48,314)	(571,031)	(387,800)	(19,032)	(31,967)	(760,394)		(468,081)
Segment assets	$9,647,926	$4,568,775	$22,443,029	$32,188,362	$471,582	$598,554	$32,562,537	$-	$37,355,691

Condensed financial information with respect to these reportable business segments for the six months ended October 31, 2011 and 2010 is as follows:

	Chinese  Medicines		Stevioside		Corporate and Other		Consolidated
(Unaudited)	2011	2010	2011	2010	2011	2010	2011		2010
Net revenues	$1,609,425	$1,015,535	$4,806,191	$3,616,081	-	-	$6,415,616		$4,631,616
Interest income	6,139	2,238	18,981	15,959	7,373	-	32,493		18,197
Depreciation and amortization	38,762	36,053	714,391	737,244	-	-	753,153		773,297
Loss from continuing operations before taxes and noncontrolling interest	(385,926)	(191,918)	(945,383)	(435,302)	(449,404)	(178,173)	(1,780,713)		(805,393)
Segment assets	$9,647,926	$4,568,775	$22,443,029	$32,188,362	$471,582	$598,554	$32,562,537	$-	$37,355,691